MTIF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.923600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.018400E-01
Normal-vs-Stage2
5.280800E-01
Normal-vs-Stage3
8.889600E-02
Normal-vs-Stage4
7.619400E-01
Stage1-vs-Stage2
8.607800E-01
Stage1-vs-Stage3
1.285990E-01
Stage1-vs-Stage4
2.894400E-01
Stage2-vs-Stage3
5.383800E-02
Stage2-vs-Stage4
2.283800E-01
Stage3-vs-Stage4
5.011800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.345800E-01
Normal-vs-AfricanAmerican
4.083000E-01
Normal-vs-Asian
2.152800E-01
Caucasian-vs-AfricanAmerican
6.798600E-01
Caucasian-vs-Asian
3.334200E-01
AfricanAmerican-vs-Asian
7.507400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.497000E-01
Normal-vs-Female
4.416400E-01
Male-vs-Female
4.660400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.825200E-01
Normal-vs-Age(41-60Yrs)
4.641000E-01
Normal-vs-Age(61-80Yrs)
4.594600E-01
Normal-vs-Age(81-100Yrs)
9.942000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.208200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.440000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.856400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.872400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.988000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.739040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.511800E-01
Normal-vs-Daily Drinker
4.520600E-01
Normal-vs-Weekly Drinker
7.876000E-01
Normal-vs-Occasional Drinker
7.865800E-01
Normal-vs-Social Drinker
6.718600E-01
Non Drinker-vs-Daily Drinker
9.895800E-01
Non Drinker-vs-Weekly Drinker
5.168200E-01
Non Drinker-vs-Occasional Drinker
6.309800E-02
Non Drinker-vs-Social Drinker
1.586450E-01
Daily Drinker-vs-Weekly Drinker
5.338400E-01
Daily Drinker-vs-Occasional Drinker
1.716400E-01
Daily Drinker-vs-Social Drinker
3.283200E-01
Weekly Drinker-vs-Occasional Drinker
7.679000E-01
Weekly Drinker-vs-Social Drinker
9.083600E-01
Occasional Drinker-vs-Social Drinker
7.490800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.059800E-01
Normal-vs-Grade 2
8.237500E-02
Normal-vs-Grade 3
4.271600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.335900E-02
Grade 1-vs-Grade 3
2.441400E-03
Grade 1-vs-Grade 4
2.059800E-01
Grade 2-vs-Grade 3
8.009500E-02
Grade 2-vs-Grade 4
8.237500E-02
Grade 3-vs-Grade 4
4.271600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.464000E-01
Normal-vs-NonDiabetic
3.600200E-01
Diabetic-vs-NonDiabetic
7.711400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.699400E-01
Normal-vs-NoPancreatitis
4.272000E-01
Pancreatitis-vs-NoPancreatitis
7.006600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.933800E-01
Normal-vs-N1
5.327600E-01
N0-vs-N1
9.755600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.794800E-01
Normal-vs-TP53-NonMutant
7.996400E-01
TP53-Mutant-vs-TP53-NonMutant
2.424200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
